TESS Research Foundation: Treatment / Cure for SLC13A5 Deficiency (Epilepsy)
| Name: |
TESS Research Foundation: Treatment / Cure for SLC13A5 Deficiency (Epilepsy) Application deadline: 04/04/17 |
|---|---|
| General description: |
The purpose of this grant is to fund research focused on understanding the disease mechanism and finding treatment options for the epileptic encephalopathy caused by mutations in the SLC13A5 gene. Funding: Up to maximum $100,000 for 1/2 years. |
| Source: | Foreign |
| Budget: | $100,000 |
| Number of research years: | 1-2 |
| Contact person: | Robi, 2152, robertg@trdf.technion.ac.il; iris 1769, irisbr@trdf.technion.ac.il |
| Fields: | Life Sciences and medicine |
| Type of fund: | The fund is not a competitive fund |
| Related fund and profiles: | TESS Research Foundation ,Access available for Technion staff. Please sign in to see the Agency profiles (upper left corner) |